National Biotechnology Regulatory Authority

Rediff.com » News » National Biotechnology Regulatory Authority

News for National Biotechnology Regulatory Authority

News
Business

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots......

3 COVID vaccines under active consideration: Health ministry

Three COVID-19 vaccines, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is......

Modi@2: Hits and misses in science and tech

'Well begun is half done, today there are more hits than misses by the Modi government in its support towards science in India,' says Pallava Bagla. Modi@2 Is the glass of science half-full or......

GEAC clears environmental release of GM mustard

The Genetic Engineering Appraisal Committee (GEAC) has recommended the environmental release of the genetically modified (GM) mustard variety DMH (Dhara Mustard Hybrid)-11, paving the way for the......

'Mumbai needs a CEO to become a global financial hub'

There is a need to have a 'CEO for Mumbai' in order to realise the ambition of making it a global financial centre, says a report. "Mumbai needs a much simpler and more empowered governance......

Zombie wheat case: GM food safety debate far from settled

Efforts by Indian activists to challenge the Biotechnology Regulatory Authority Bill, now pending in Parliament, may get a boost from a controversy that has broken out in the US Agricultural......

COLUMN: Why there's a twist in the GM tale

Agricultural scientists are all for gene-altered crops that are safe for the environment and health and are beneficial to farmers, notes Surinder Sud. By raising frivolous objections to the......

Pharmaceuticals - No significant booster doses

The Indian pharmaceutical market is forecasted to grow at an estimated CAGR of 16% between 2010 and 2015 and cross USD 20 billion. It is projected to be the third largest global pharmaceuticals......

Rediff News

National Biotechnology Regulatory Authority

News for National Biotechnology Regulatory Authority

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021

3 COVID vaccines under active consideration: Health ministry

Modi@2: Hits and misses in science and tech

GEAC clears environmental release of GM mustard

'Mumbai needs a CEO to become a global financial hub'

Zombie wheat case: GM food safety debate far from settled

COLUMN: Why there's a twist in the GM tale

Pharmaceuticals - No significant booster doses

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS